index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

Dystrophine Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Homeostasis Duchenne DMD dystrophy Cell Line Skeletal muscle Dynamin 2 Calcium Channels Genomic Allele‐specific silencing therapy Mdx mouse Modificateurs de gènes Delivery Cells Humans Cell Biology Muscles/physiopathology Inbred mdx Dystrophin central domain CaV subunits Metabolism Energy Metabolism/drug effects Muscle Muscular dystrophy Mitochondrial fission Multi exon skipping Muscle Strength Base Sequence Cultured Clinical trials Knockout Génomique Exon skipping Dystrophie musculaire de Becker Antisense oligonucleotides LKB1 Diseases MES Becker BMD muscular dystrophy Myogenesis MiARN CTNNB1 L-Type Dystrophin Duchenne muscular dystrophy Centronuclear myopathy Inbred C57BL Dystrophy Male Activin Receptors Multiresolution modeling Animal/physiopathology Hepatocellular carcinoma Inhibitors Multi resolution modeling NAD+ Muscle development Calcium Myotendinous junction Cardiomyopathy DMO Long QT Liver Becker muscular dystrophy BMD Dystrophin-EGFP Human Umbilical Vein Endothelial Cells Animals Gene expression LncRNA Becker muscular dystrophy Long noncoding RNA Duchenne muscular dystrophy DMD Gene Expression Regulation/drug effects Invivo CD38 CaVβs Dystrophie Musculaire de Duchenne DMD Ex-vivo Immunoglobulin Fc Fragments/pharmacology Muscular Atrophy Drp1 NNOS Dystrophie Musculaire de Becker BMD Cachexia Molecular Sequence Data Cell homeostasis BMD Gene modifiers LncARN Hear Muscle Biology Cardiomyopathie Autophagy Molecular docking Mice DMD Epigenetics DHPR α1S Muscular Dystrophy Morphogenesis